MedPath

Host DNA Methylation for Endometrial Cancer Screening

Conditions
DNA Methylation
Cohort Study
Liquid Biopsy
Cancer Screening
Endometrial Cancer
Cervical Cytology
Registration Number
NCT05290415
Lead Sponsor
Lei Li
Brief Summary

Based on the previous study of NCT04651738, we performed this trial to further confirm the accuracy of host DNA CDO1 and CELF4 methylation for endometrial cancer screening in a multi-center cohort. Thirteen hospitals, including Peking Union Medical College Hospital, would enroll eligible patients in this study. The cervical cytology of 3 ml will be collected for the detection of DNA CDO1 and CELF4 methylation, and the results will compared with the endometrial histological pathology, which is achieved after collection of cervical cytology, by surgeries including hysteroscopy, dilation and curettage, total hysterectomy and others. The methylation testing would be double-blinded in operators and analysts. The study will enroll at least 10,000 patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
10000
Inclusion Criteria
  • With uterine and uterine cervix intact
  • Aged 18 years or older
  • With accessible histological results of endometrium
  • Signed an approved informed consents
  • With accessible cervical cytology before harvesting endometrial histology
Exclusion Criteria
  • Not meeting all of the inclusion criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sensitivity of methylation testingOne week

Sensitivity of methylation testing of cervical cytology compared with histology

Specificity of methylation testingOne week

Specificity of methylation testing of cervical cytology compared with histology

Secondary Outcome Measures
NameTimeMethod
Positive predictive value of methylation testingOne week

Positive predictive value of methylation testing of cervical cytology compared with histology

Negative predictive value of methylation testingOne week

Negative predictive value of methylation testing of cervical cytology compared with histology

Trial Locations

Locations (1)

Lei Li

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath